Abstract
Modifications of histone tails, including
lysine/arginine methylation, provide the basis of a 'chromatin or histone
code'. Proteins that contain 'reader' domains can bind to these modifications
and form specific effector complexes, which ultimately mediate chromatin
function. The spindlin1 (SPIN1) protein contains three Tudor
methyllysine/arginine reader domains and was identified as a putative oncogene
and transcriptional co-activator. Here we report a SPIN1 chemical probe
inhibitor with low nanomolar in vitro activity, exquisite selectivity on a
panel of methyl reader and writer proteins, and with submicromolar cellular
activity. X-ray crystallography showed that this Tudor domain chemical probe
simultaneously engages Tudor domains 1 and 2 via a bidentate binding mode.
Small molecule inhibition and siRNA knockdown of SPIN1, as well as
chemoproteomic studies, identified genes which are transcriptionally regulated
by SPIN1 in squamous cell carcinoma and suggest that SPIN1 may have a roll in
cancer related inflammation and/or cancer metastasis.
Supplementary materials
Title
SI data
Description
Actions
Title
SI Fagan et al
Description
Actions
Title
TOC
Description
Actions